Analysis of presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors
Kyle Annen, Thomas E. Morrison, Melkon G. DomBourian, Mary K. McCarthy, Leah Huey, Patricia Merkel, Gillian Andersen, Eileen Schwartz, Vijaya Knight
doi: https://doi.org/10.1101/2020.09.01.20185942
Kyle Annen
1Department of Pathology and Laboratory Medicine, University of Colorado School of Medicine and Children’s Hospital, Colorado
D.O.Thomas E. Morrison
2Department of Immunology and Microbiology, University of Colorado School of Medicine
Ph.D.Melkon G. DomBourian
1Department of Pathology and Laboratory Medicine, University of Colorado School of Medicine and Children’s Hospital, Colorado
M.D.Mary K. McCarthy
2Department of Immunology and Microbiology, University of Colorado School of Medicine
Ph.D.Leah Huey
3Department of Pediatrics, Section of Allergy and Immunology, University of Colorado School of Medicine and Children’s Hospital, Colorado
B.S.Patricia Merkel
3Department of Pediatrics, Section of Allergy and Immunology, University of Colorado School of Medicine and Children’s Hospital, Colorado
M.S.Gillian Andersen
1Department of Pathology and Laboratory Medicine, University of Colorado School of Medicine and Children’s Hospital, Colorado
M.S., MT(ASCP)Eileen Schwartz
1Department of Pathology and Laboratory Medicine, University of Colorado School of Medicine and Children’s Hospital, Colorado
RNVijaya Knight
3Department of Pediatrics, Section of Allergy and Immunology, University of Colorado School of Medicine and Children’s Hospital, Colorado
M.D., Ph.D.Article usage
Posted September 03, 2020.
Analysis of presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors
Kyle Annen, Thomas E. Morrison, Melkon G. DomBourian, Mary K. McCarthy, Leah Huey, Patricia Merkel, Gillian Andersen, Eileen Schwartz, Vijaya Knight
medRxiv 2020.09.01.20185942; doi: https://doi.org/10.1101/2020.09.01.20185942
Analysis of presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors
Kyle Annen, Thomas E. Morrison, Melkon G. DomBourian, Mary K. McCarthy, Leah Huey, Patricia Merkel, Gillian Andersen, Eileen Schwartz, Vijaya Knight
medRxiv 2020.09.01.20185942; doi: https://doi.org/10.1101/2020.09.01.20185942
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2833)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12534)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2840)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)